Alessandra Narcisi

2.3k total citations
105 papers, 886 citations indexed

About

Alessandra Narcisi is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Alessandra Narcisi has authored 105 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Dermatology, 50 papers in Immunology and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Alessandra Narcisi's work include Psoriasis: Treatment and Pathogenesis (46 papers), Dermatology and Skin Diseases (40 papers) and Autoimmune Bullous Skin Diseases (15 papers). Alessandra Narcisi is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (46 papers), Dermatology and Skin Diseases (40 papers) and Autoimmune Bullous Skin Diseases (15 papers). Alessandra Narcisi collaborates with scholars based in Italy, United States and Australia. Alessandra Narcisi's co-authors include Antonio Costanzo, Mario Valenti, Luigi Gargiulo, Giulia Pavia, Luciano Ibba, Paola Facheris, Riccardo G. Borroni, Elisabetta Botti, Diego Orsini and Marta Carlesimo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and FEBS Letters.

In The Last Decade

Alessandra Narcisi

96 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alessandra Narcisi Italy	19	459	448	155	145	140	105	886
Athanasios Tsianakas Germany	20	398 0.9×	552 1.2×	114 0.7×	252 1.7×	100 0.7×	57	1.1k
D. Staumont‐Sallé France	21	388 0.8×	523 1.2×	120 0.8×	308 2.1×	117 0.8×	101	1.2k
E. Castela France	12	442 1.0×	438 1.0×	100 0.6×	68 0.5×	54 0.4×	14	860
Svitlana Tatulych United States	11	354 0.8×	523 1.2×	73 0.5×	302 2.1×	121 0.9×	17	847
Szu‐Ying Chu Taiwan	8	301 0.7×	359 0.8×	132 0.9×	102 0.7×	42 0.3×	9	677
Annamaria Mazzotta Italy	16	756 1.6×	448 1.0×	110 0.7×	193 1.3×	55 0.4×	29	901
M. Tauber France	16	319 0.7×	419 0.9×	60 0.4×	156 1.1×	45 0.3×	63	837
Vimal H. Prajapati Canada	13	249 0.5×	588 1.3×	89 0.6×	179 1.2×	49 0.3×	87	861
Emanuela Martina Italy	17	222 0.5×	285 0.6×	121 0.8×	195 1.3×	37 0.3×	49	770
Tomoko Kawashima Japan	10	300 0.7×	170 0.4×	101 0.7×	54 0.4×	220 1.6×	21	846

Countries citing papers authored by Alessandra Narcisi

Since Specialization

Citations

This map shows the geographic impact of Alessandra Narcisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Narcisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Narcisi more than expected).

Fields of papers citing papers by Alessandra Narcisi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Narcisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Narcisi. The network helps show where Alessandra Narcisi may publish in the future.

Co-authorship network of co-authors of Alessandra Narcisi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Narcisi. A scholar is included among the top collaborators of Alessandra Narcisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Narcisi. Alessandra Narcisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valenti, Mario, Luciano Ibba, S. Di Giulio, et al.. (2025). Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis). Journal of Dermatological Treatment. 36(1). 2456532–2456532.

Giulio, S. Di, Luigi Gargiulo, Mario Valenti, et al.. (2025). Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study. Journal of Clinical Medicine. 14(18). 6371–6371.

Gargiulo, Luigi, Luciano Ibba, Alessandra Narcisi, et al.. (2025). Using Biologics to Reduce Long‐Term Corticosteroid Use in Pyoderma Gangrenosum: Real‐World Evidence From Two Centres. Australasian Journal of Dermatology. 66(5). 305–308.

Stark, Michael, et al.. (2025). Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real‐World Clinical Outcomes and Lipid Profile Evaluation. Australasian Journal of Dermatology. 66(8). 468–474.

Paolino, Giovanni, Mario Valenti, Andrea Carugno, et al.. (2025). Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management. Medicina. 61(1). 54–54. 2 indexed citations

Bianco, M.A., S. Di Giulio, Paola Facheris, et al.. (2025). New and Emerging Biologics and Jak Inhibitors for the Treatment of Prurigo Nodularis: A Narrative Review. Medicina. 61(4). 631–631. 1 indexed citations

Ibba, Luciano, et al.. (2024). Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review. Clinical Cosmetic and Investigational Dermatology. Volume 17. 593–604. 11 indexed citations

Amerio, Paolo, Silvia Mariel Ferrucci, Marco Galluzzo, et al.. (2024). A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis. Dermatology and Therapy. 14(6). 1443–1455. 4 indexed citations

Valenti, Mario, Luciano Ibba, Piergiorgio Malagoli, et al.. (2024). A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis). Dermatology and Therapy. 14(11). 2987–2997.

10.

Ibba, Luciano, S. Di Giulio, Luigi Gargiulo, et al.. (2024). Long-term effectiveness and safety of risankizumab in patients with moderate-to-severe psoriasis with and without cardiometabolic comorbidities: a single-center retrospective study. Journal of Dermatological Treatment. 35(1). 2425029–2425029. 6 indexed citations

11.

Cortese, Andrea, Luigi Gargiulo, Luciano Ibba, et al.. (2023). Anti-IL17 and anti-IL23 biologic drugs for genital psoriasis: a single-center retrospective comparative study. Dermatology Reports. 15(3). 9692–9692. 2 indexed citations

12.

Orsini, Diego, Luciano Ibba, Alessandra Narcisi, et al.. (2023). Long-term management of pediatric psoriasis with ixekizumab: a case report. Journal of Dermatological Treatment. 34(1). 2198622–2198622. 2 indexed citations

13.

Favaro, Rebecca, Giulia Pavia, Luigi Gargiulo, et al.. (2023). The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV-2 infection and vaccination. British Journal of Dermatology. 189(5). 635–637.

14.

Gargiulo, Luigi, Luciano Ibba, Mario Valenti, et al.. (2023). Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience. Journal of Dermatological Treatment. 34(1). 2192840–2192840. 3 indexed citations

15.

Ibba, Luciano, Luigi Gargiulo, Giulia Pavia, et al.. (2023). A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks. Dermatology Reports. 16(1). 9722–9722. 2 indexed citations

16.

Malagoli, Piergiorgio, Paolo Dapavo, Giulia Pavia, et al.. (2022). Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study— IL PSO ( Italian landscape psoriasis). Dermatologic Therapy. 35(8). e15608–e15608. 10 indexed citations

17.

Pavia, Giulia, Luigi Gargiulo, Andrea Cortese, et al.. (2021). Apremilast for the treatment of palmo‐plantar non‐pustular psoriasis: A real‐life single‐center retrospective study. Dermatologic Therapy. 35(2). e15253–e15253. 7 indexed citations

18.

Narcisi, Alessandra, Mario Valenti, Andrea Cortese, et al.. (2021). Anti‐IL17 and anti‐IL23 biologic drugs for scalp psoriasis: A single‐center retrospective comparative study. Dermatologic Therapy. 35(2). e15228–e15228. 27 indexed citations

19.

Valenti, Mario, Giulia Pavia, Luigi Gargiulo, et al.. (2021). Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital. International Journal of Dermatology. 60(7). 860–863. 22 indexed citations

20.

Pavia, Giulia, Luigi Gargiulo, Mario Valenti, et al.. (2020). Skin cancers: how to balance the risks and benefits of surgery during COVID‐19 pandemic (a Northern Italy single‐center experience). International Journal of Dermatology. 59(10). 1287–1289. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact